• English
  • عربي / Arabic
  • മലയാളം / Malayalam

Lung Oncology - FAQ

FAQ's

Early-stage lung cancer may not cause noticeable symptoms. However, common warning signs include:

  • Persistent cough lasting more than 2–3 weeks
  • Coughing up blood (hemoptysis)
  • Chest pain that worsens with breathing or coughing
  • Shortness of breath
  • Unexplained weight loss
  • Fatigue
  • Recurrent chest infections

Low-dose CT screening is recommended for high-risk individuals, especially long-term smokers, as early detection significantly improves survival rates.

Lung cancer diagnosis involves advanced imaging and biopsy procedures to confirm cancer type and stage.

Common diagnostic tests include:

  • Low-dose CT scan for screening
  • High-resolution CT scan of the chest
  • PET-CT scan for staging
  • Bronchoscopy with biopsy
  • Endobronchial ultrasound (EBUS) for lymph node evaluation
  • Image-guided lung biopsy
  • Molecular and genetic testing to guide targeted therapy

Accurate staging and molecular profiling help determine the most effective personalized treatment plan.


Treatment depends on the type (NSCLC or SCLC), stage, and molecular characteristics of the tumor. Options may include:

  • Minimally invasive or robotic-assisted lung cancer surgery
  • Chemotherapy
  • Targeted therapy based on genetic mutations
  • Immunotherapy
  • Precision radiation therapy
  • Combined multimodal treatment for advanced cases

A multidisciplinary tumor board reviews each case to ensure personalized, evidence-based treatment aimed at preserving lung function and improving long-term outcomes.


Our Doctors

View More

Real Voices That Matter